Candel Therapeutics, Inc 10-Q for FY2023 Q2
Candel Therapeutics, Inc. (CADL)
10-Q
2023-08-10
For: 2023-06-30
View Original
Added on
April 10, 2026
About this 10-Q
Candel Therapeutics, Inc filed this 10-Q on August 10, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $9.61M
- compared with a net loss of $4.15M a year earlier
- Diluted EPS
- -$0.33
- compared with -$0.14 a year earlier